WATERTOWN, Mass. — August 27, 2025 — Leads & Copy — Kymera Therapeutics, Inc. (NASDAQ: KYMR) will participate in fireside chats at investor events, including the Citi 2025 Biopharma Back to School Conference, Wells Fargo 2025 Healthcare Conference, Morgan Stanley 23rd Annual Global Healthcare Conference, and Stifel 2025 Virtual Immunology and Inflammation Forum.
Live webcasts will be available in the “News and Events” section of the company’s website. Replays will be archived after the events.
Kymera Therapeutics is focused on targeted protein degradation (TPD) to develop medicines.
Justine Koenigsberg, Vice President of Investor Relations, can be reached at investors@kymeratx.com, media@kymeratx.com or 857-285-5300.
Source: Kymera Therapeutics
